WallStreetZenWallStreetZen

NASDAQ: MPLT
Maplight Therapeutics Inc Stock Ownership - Who owns Maplight Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maplight Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Woodruff LillieCSci2026-10-1511,513$8.08
$93.03kSell
Christopher A. KroegerCEO2026-10-1573,691$8.08
$595.42kSell
Anatol KreitzerCXO2026-10-1512,248$7.84
$96.02kSell
Jonathan GillisCFO;CAO;Interim2026-10-1510,167$8.08
$82.15kSell
Erin Pennock FoffMed2026-10-1515,355$8.08
$124.07kSell
Kristopher HansonCLO2026-10-159,020$8.08
$72.88kSell
Kristopher HansonCLO2026-09-1616,509$11.67
$192.66kSell
Catalyst4 Inc10% Owner2026-08-144,400,000$11.38
$50.07MBuy
James Woodruff LillieCSci2026-08-0322,082$12.54
$276.91kSell
Catalyst4 Inc10% Owner2026-07-301,000,000$13.00
$13.00MBuy

1 of 17

MPLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MPLT insiders and whales buy or sell their stock.

MPLT Shareholders

What type of owners hold Maplight Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Catalyst4 Inc97.04%45,004,153$359.13MInsider
Holdings A. Novo7.95%3,686,622$29.42MInsider
Christopher A. Kroeger3.01%1,398,289$11.16MInsider
Vishwas Setia0.77%356,256$2.84MInsider
Robert C. Malenka0.75%348,138$2.78MInsider
Erin Pennock Foff0.64%296,906$2.37MInsider
James Woodruff Lillie0.43%198,597$1.58MInsider
Anatol Kreitzer0.36%168,678$1.35MInsider
Jonathan Gillis0.31%142,315$1.14MInsider
Kristopher Hanson0.28%128,024$1.02MInsider

1 of 3

MPLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MPLT0.05%99.95%Net BuyingNet Buying
CYPH0.01%99.99%Net BuyingNet Buying
GALT0.01%99.99%Net BuyingNet Buying
KYTX0.06%42.88%Net Buying
SPRY0.09%99.91%Net Selling
View Top Biotech Stocks

Maplight Therapeutics Stock Ownership FAQ

Who owns Maplight Therapeutics?

Maplight Therapeutics (NASDAQ: MPLT) is owned by 0.06% institutional shareholders, 111.96% Maplight Therapeutics insiders, and 0.00% retail investors. Catalyst4 Inc is the largest individual Maplight Therapeutics shareholder, owning 45.00M shares representing 97.04% of the company. Catalyst4 Inc's Maplight Therapeutics shares are currently valued at $347.43M.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.